ARTICLE | Company News
Immunomedics other research news
March 27, 1995 8:00 AM UTC
The Morris Plains, N.J., company received a $100,000 Phase I SBIR from the National Cancer Institute to determine whether a humanized lymphoma-targeting antibody labeled with the radioisotope Yttrium-...